PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Koncept Analytics

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Koncept Analytics Publishes Global Intravenous IV Iron Drugs Market - 2011 Edition - The present report analyzes the global IV iron market, with focus on some of the major regional markets, including the US, Europe and Switzerland - KonceptAnalytics.com
Koncept Analytics Publishes Global Intravenous IV Iron Drugs Market - 2011 Edition

 

NewswireToday - /newswire/ - Delhi, New Delhi, India, 2012/02/01 - The present report analyzes the global IV iron market, with focus on some of the major regional markets, including the US, Europe and Switzerland - KonceptAnalytics.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Iron is one of the most important minerals present in the human body and performs the task of carrying oxygen throughout the body through blood, which is then further utilized by the cells to get energy. Decline in iron can therefore lead to certain major problems. Although oral iron supplements can be used to maintain the iron levels in the body, but oral supplements are chronic treatments and generally have poor absorption, poor compliance, and can have certain side effects. In such cases, IV iron therapy proves out to be the best option. Presently, oral iron dominates the global iron market, holding more than half of the market. But with the increasing use of IV iron, its share is expected to increase and surpass that of oral iron.

The global market for IV iron is increasing in the past years. Nephrology remains the largest segment of use for the IV iron therapies, and accounts for more than three-fourths of the overall market. With the ongoing research and development to increase the use of IV iron therapies in other therapeutic areas, including gynaecology, gastroenterology, oncology, chronic heart failures and surgeries, the IV iron market would certainly benefit. There are certain types of IV iron products being marketed and used worldwide, some of which include low molecular weight iron dextran, iron sucrose, ferric gluconate, and ferric carboxylmaltose. The US is the largest IV iron market worldwide, followed by European Union.

The report broadly includes the following:

1. Intravenous (IV) Iron: An Introduction

2. IV Iron Market
2.1 Global Market for Iron Products
2.2 Global IV Iron Market

3. Major IV Iron Regional Markets
3.1 The US IV Iron Market
3.2 European Union Iron Market

4. Growth Drivers

5. Key Issues

6. Company Profiles
6.1 Galenica Pharmaceuticals
6.2 Watson Pharmaceuticals
6.3 AMAG Pharmaceuticals

7. Market Outlook

List of Charts
Global Market for Iron Products (2006-2010)
Global Iron Products Market – Share by Segments (2010)
Global IV Iron Market (2006-2010)
IV Iron Market – Share by Area of Use (2010)
Global IV Iron Market – Share by Major Products (2006-2010)
US IV Iron Replacement Market – by Volume (2008-2010)
US IV Iron Replacement Market – Volume Share by Category of Use (2010)
US IV Iron Replacement Market – Volume Share by Products (2010)
US CKD Patient Profile
US Non-Dialysis IV Iron Market – by Quarter (Q110-Q311)
European IV Iron Market – by Volume (MAT2007-MAT2011)
IV Iron Usage in Switzerland by Value (2006-2010)
IV Iron Market Volume in Switzerland – by Products Categories (2002-2010)
IV Iron Usage in Switzerland – Value Share by Therapeutic Area (2010)
IV Iron Usage Growth by Therapeutic Area in Switzerland (2007-2010)
Stages of Chronic Kidney Disease (CKD)
Dialysis Patients Worldwide (2005-2010)
World Population with Diabetes, Age Group 20-79 years (2006-2012)
Ageing Population Worldwide, age>60 year (2008-2014E)
Global Female Population: age 15-44 years (2008-2014E)
IV Iron – Avoidance of ESA Initiation in Pre Dialysis Patients
IV Iron – Response Rate to ESA Therapy with or without IV Iron
IV Iron Cost Structure – by Products
Long & Short Term Concerns about IV Iron
Galenica Pharmaceuticals Revenue – Share by Segments (2010)
Vifor Pharma IV Iron Replacement Products – Revenue (2009-2010)
Watson Pharmaceuticals Revenue (2007-2010)
Watson Pharmaceuticals Revenue – Share by Segments (2010)
AMAG Pharmaceuticals – Revenue (2007-2010)
Feraheme Revenue (2009-2010)
Global IV Iron Market Forecasts (2010-2015E)

List of Tables
Comparison of Major IV Iron Preparations
Timeline of IV Iron Development in the US (1932-Present)
IV Iron Products – Administration Statistics
IV Iron Products – Safety Profile
Dependent & Independent Variables (2006-2010)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Koncept Analytics

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Koncept Analytics Publishes Global Intravenous IV Iron Drugs Market - 2011 Edition

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Vikas Gupta - KonceptAnalytics.com 
+91 120-4130959 vikas[.]konceptanalytics.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Koncept Analytics securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Koncept Analytics / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  NAKIVO, Inc.





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)